Have you heard of Tirzepatide? If you haven’t, I’m certain you will be hearing about it soon.
Because Tirzepatide (trade name Mounjaro), is finally now available at pharmacies in Canada. We have been waiting a year due to the global shortages of this medication.
Tirzepatide is a GIP/GLP1 dual agonist. It is very effective for improving blood sugar control and helping people with type 2 diabetes and obesity lose weight. This medication has shown outstanding blood sugar control and weight loss results according to the trials.
I’m Dr. Sasha High, an obesity physician practicing since 2012. I’m one of the leading Canadian physicians in obesity and in this podcast episode, I answer all your curious questions about this new treatment for obesity including:

How does Tirzepatide work?
How do you take Tirzepatide?
What are the side effects?
How much does Tirzepatide cost?
Will your insurance cover Tirzepatide?
Should I switch over to Tirzepatide?

References:

Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131–2157

 
FOLLOW SASHA Instagram - https://www.instagram.com/sashahighmd/ Tiktok - https://www.tiktok.com/@sashahighmd

Ver todos los episodios